You are here
L2 DIAGNOSTICS LLC
UEI: GKA7VH5LFR25
# of Employees: 15
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Preclinical development of the tsetse thrombin inhibitor
Amount: $98,179.00DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Despite the need for effective therapies for treating and preventing pat ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Isoaspartyl Modified Tumor Antigens for Vaccination
Amount: $99,829.00DESCRIPTION (provided by applicant): This proposal will take advantage of several unique observations made in understanding the properties of self proteins that regulate the development of autoimmune ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Therapeutic Activity of a Novel Tick Immunosuppressant
Amount: $99,728.00DESCRIPTION (provided by applicant): The overall objective of this proposal is to evaluate the therapeutic potential of a novel immunosuppressant protein produced by tick salivary glands. Ixodes sca ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
A novel platelet inhibitor from bloodfeeding hookworms
Amount: $99,383.00DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Because platelets play a critical role in the activation and propagati ...
STTRPhase I2003Department of Health and Human Services National Institutes of Health -
Vaccine therapy of congenital adrenal Hyperplasia
Amount: $135,039.00N/A
STTRPhase I2003Department of Health and Human Services National Institutes of Health -
A Novel Family of Anticoagulants from Ixodes scapularis
Amount: $138,854.00DESCRIPTION (provided by applicant): The overall objective of this proposal is to evaluate the anticoagulant properties of a family of novel tick salivary proteins Ixodes scapularis, the black-legged ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Vaccination Against West Nile Virus
Amount: $729,355.00DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Vaccination Against West Nile Virus
Amount: $0.00DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
VACCINATION AGAINST IXODES SCAPULARIS TICK BITES
Amount: $0.00DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgd ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
VACCINATION AGAINST IXODES SCAPULARIS TICK BITES
Amount: $748,024.00DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgd ...
SBIRPhase II2002Department of Health and Human Services National Institutes of Health